<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7251277\results\search\disease\results.xml">
  <result pre="OBJECTIVE: Turkey is one of the latest countries that COVID-19" exact="disease" post="was reported, with the first case on March 11,"/>
  <result pre="the patients were tested positive for the COVID-19 by qRT-PCR." exact="Viral" post="RNA extraction was performed from the same swab samples."/>
  <result pre="(an asymptomatic patient, patient with mild disease, and with severe" exact="pulmonary" post="infiltration). Amplicon-based next-generation sequencing approach successfully applied to generate"/>
  <result pre="near-complete genomes with an average depth of 2.616. All three" exact="viral" post="genomes carried the D614G variant (G clade according to"/>
  <result pre="to Europe then to Istanbul. CONCLUSION: Here, we report the" exact="viral" post="genomes circulating in Istanbul for the first time. Further"/>
  <result pre="the virus isolates may enable us to understand variations in" exact="disease" post="presentation and association with viral factors if there is"/>
  <result pre="us to understand variations in disease presentation and association with" exact="viral" post="factors if there is any. In addition, the sequencing"/>
  <result pre="if there is any. In addition, the sequencing of more" exact="viral" post="genomes will delineate the spread of disease and will"/>
  <result pre="sequencing of more viral genomes will delineate the spread of" exact="disease" post="and will guide and ease the necessary measures taken"/>
  <result pre="the spread of the novel coronavirus. COVID-19 SARS-CoV-2 whole-genome sequencing" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease"/>
  <result pre="spread of the novel coronavirus. COVID-19 SARS-CoV-2 whole-genome sequencing Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019"/>
  <result pre="of the novel coronavirus. COVID-19 SARS-CoV-2 whole-genome sequencing Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19),"/>
  <result pre="the novel coronavirus. COVID-19 SARS-CoV-2 whole-genome sequencing Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), was"/>
  <result pre="sequencing Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus" exact="disease" post="2019 (COVID-19), was first detected in Wuhan, China, around"/>
  <result pre="the emergence of the outbreak to other countries in a" exact="short" post="period, the World Health Organization declared COVID-19 as a"/>
  <result pre="[3, 4]. Coronaviruses were thought to result in seasonal mild" exact="respiratory" post="illness in humans until the epidemics of the SARS-CoV"/>
  <result pre="of taste and/or smell [7, 8]. In addition to the" exact="symptomatic" post="patients, initial studies showed that a considerable amount of"/>
  <result pre="rates increase with patientâ€™s age [12]. The severity of the" exact="infection" post="is related to the age of the patient and"/>
  <result pre="the age of the patient and the presence of additional" exact="chronic" post="diseases, such as hypertension, diabetes, and cancer [13]. Besides"/>
  <result pre="presence of additional chronic diseases, such as hypertension, diabetes, and" exact="cancer" post="[13]. Besides challenges on detecting evidence on virulence changes"/>
  <result pre="and pathogenicity of the viruses [17]. Although SARS-CoV-2 has a" exact="lower" post="mutation rate than expected [18], real-time tracking of the"/>
  <result pre="virus isolates in populations may help epidemiological understanding of the" exact="disease" post="and early detection of important mutational or recombination events."/>
  <result pre="a written informed consent was obtained from all participating patients." exact="Viral" post="RNA Extraction: Viral RNA was extracted from 200 Âµl"/>
  <result pre="consent was obtained from all participating patients. Viral RNA Extraction:" exact="Viral" post="RNA was extracted from 200 Âµl of nasopharyngeal swab"/>
  <result pre="from 200 Âµl of nasopharyngeal swab samples with High Pure" exact="Viral" post="RNA Kit (Roche Life Science) according to the manufacturerâ€™s"/>
  <result pre="Extracted RNA was eluted in 45 Âµl of DNase/RNase-free water." exact="Total" post="RNA concentration was determined with Qubit 4.0 Fluorometer using"/>
  <result pre="Qubit 4.0 Fluorometer using Qubit RNA HS Assay Kit (Thermo" exact="Fisher" post="Scientific Inc.) and RNA quality was evaluated at 260/280"/>
  <result pre="RNA samples were stored at âˆ’80 Â°C until further processing." exact="Viral" post="Genome Sequencing and Data Analysis: Sequencing libraries were generated"/>
  <result pre="each sample. Briefly, reverse transcription of RNA was performed; the" exact="viral" post="genome was amplified with multiplex PCRs followed by indexing"/>
  <result pre="Qubit dsDNA HS Assay Kit with Qubit 4.0 Fluorometer (Thermo" exact="Fisher" post="Scientific Inc.) and an Agilent Bioanalyzer 2100 with High"/>
  <result pre="[22]. Further, primer sequences were trimmed from aligned bam files." exact="Variant" post="calling and generating consensus sequences were performed using Samtools"/>
  <result pre="to detect the presence of any sequencing errors, if any." exact="Viral" post="genome sequences were examined phylogenetically together with world-wide isolates"/>
  <result pre="a 50 packs-year history and had a medical history of" exact="diabetes mellitus" post="and hypertension. The physical examination in the emergency department"/>
  <result pre="120/70 mm Hg, the pulse of 100 beats per minute," exact="respiratory" post="rate of 20 breaths per minute, and oxygen saturation"/>
  <result pre="was performed and reported as containing typical findings of COVID" exact="pneumonia" post="with mild involvement. Hospitalization was decided by considering the"/>
  <result pre="the normal range, and the general clinical condition was good." exact="Viral" post="RT-PCR analysis of the nasopharyngeal swab reported as positive."/>
  <result pre="auscultation. An increase in infiltrations was also detected on the" exact="chest" post="radiograph, as well as the increase in acute phase"/>
  <result pre="on the chest radiograph, as well as the increase in" exact="acute" post="phase reactants (Figure 2). Close follow-up was continued by"/>
  <result pre="inhaling in the room air. We observed that the serum" exact="acute" post="phase reactants increased and lymphopenia appeared in the complete"/>
  <result pre="We observed that the serum acute phase reactants increased and" exact="lymphopenia" post="appeared in the complete blood count test. In the"/>
  <result pre="serum acute phase reactants increased and lymphopenia appeared in the" exact="complete" post="blood count test. In the thorax CT on the"/>
  <result pre="125/70 mm Hg, the pulse of 98 beats per minute," exact="respiratory" post="rate of 20 breaths per minute, and oxygen saturation"/>
  <result pre="breathing ambient air. The remainder of the examination was normal." exact="Viral" post="RT-PCR analysis of the control nasopharyngeal swab on the"/>
  <result pre="day of illness and day of hospitalization. FIGURE 2 Posteroanterior" exact="chest" post="radiographs of COV-8 on the first (A) and the"/>
  <result pre="130/70 mm Hg, the pulse of 100 beats per minute," exact="respiratory" post="rate of 18 breaths per minute, and oxygen saturation"/>
  <result pre="Lung auscultation was normal, as well as the thorax CT." exact="Complete" post="blood count and serum acute phase reactants were in"/>
  <result pre="well as the thorax CT. Complete blood count and serum" exact="acute" post="phase reactants were in the normal range. Azithromycin and"/>
  <result pre="remaining physical examination findings were unremarkable or normal. The control" exact="viral" post="RT-PCR test for SARS-CoV-2 was reported as negative. Patient"/>
  <result pre="140/75 mm Hg, the pulse of 96 beats per minute," exact="respiratory" post="rate of 20 breaths per minute, and oxygen saturation"/>
  <result pre="Thorax CT revealed widespread patchy ground-glass opacities in both lungs." exact="Complete" post="blood count and serum acute phase reactants were in"/>
  <result pre="ground-glass opacities in both lungs. Complete blood count and serum" exact="acute" post="phase reactants were in the normal range. She was"/>
  <result pre="patient did not have a fever and did not develop" exact="respiratory" post="distress; oxygen saturation ranged between 96â€&quot;97%. The treatment was"/>
  <result pre="completely normal, for both vital signs and clinical findings. Control" exact="viral" post="RT-PCR analysis was also reported as negative. Viral Genome"/>
  <result pre="findings. Control viral RT-PCR analysis was also reported as negative." exact="Viral" post="Genome Analysis Raw sequencing data consist of 600676, 390806"/>
  <result pre="SARS-CoV-2 isolates from Istanbul Sample Nucleotide position Nucleotide change (Ref/Alt)" exact="Variant" post="type Amino acid position Amino acid change (Ref/Alt) Gene/Region"/>
  <result pre="clinical presentations (one asymptomatic, one moderate, and one with severe" exact="pulmonary" post="infiltration) were included in this study. Since the first"/>
  <result pre="to Istanbul. The Nextstrain website (www.nextstrain.org) provides real-time monitoring of" exact="viral" post="isolates around the world, mainly based on publicly accessible"/>
  <result pre="This close relationship with Belgium isolates gives clues of early" exact="viral" post="entry, at least in Istanbul, may have originated from"/>
  <result pre="of patients should be analyzed to enlighten the effects of" exact="viral" post="genetic changes on clinical outcomes. To conclude, we analyzed"/>
  <result pre="where the epicenter of the pandemic in Turkey. All three" exact="viral" post="isolates carried the D614G marker variant indicating the isolates"/>
  <result pre="efforts would also support understanding the local spread of the" exact="disease" post="but also evaluate the effectiveness of precautions, such as"/>
  <result pre="evaluate the effectiveness of precautions, such as travel restrictions on" exact="disease" post="spread in the country. Data Availability Viral genome sequences"/>
  <result pre="travel restrictions on disease spread in the country. Data Availability" exact="Viral" post="genome sequences in this research were deposited in the"/>
  <result pre="NBA, OAD, LD, GDD. References REFERENCES 1collab: World Health OrganizationCoronavirus" exact="disease" post="2019 (COVID-19):situation report, 107Accessed May 15, 2020Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200506covid-19-sitrep-107.pdf?sfvrsn=159c3dc_2"/>
  <result pre="Group of the International Committee on Taxonomy of VirusesThe species" exact="Severe" post="acute respiratory syndrome-related coronavirus:classifying 2019-nCoV and naming it SARS-CoV-2Nat"/>
  <result pre="of the International Committee on Taxonomy of VirusesThe species Severe" exact="acute" post="respiratory syndrome-related coronavirus:classifying 2019-nCoV and naming it SARS-CoV-2Nat Microbiol202055364432123347"/>
  <result pre="the International Committee on Taxonomy of VirusesThe species Severe acute" exact="respiratory" post="syndrome-related coronavirus:classifying 2019-nCoV and naming it SARS-CoV-2Nat Microbiol202055364432123347 3DallavillaTBertelliMMorresiABushatiVStuppiaLBeccariTet"/>
  <result pre="to known artificial coronavirusesEur Rev Med Pharmacol Sci20202445586432373995 4ZhouPYangXLWangXGHuBZhangLZhangWet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="5PerlmanSNetlandJCoronaviruses post-SARS:update on replication and pathogenesisNat Rev Microbiol200974395019430490 6ZumlaAHuiDSPerlmanSMiddle East" exact="respiratory" post="syndromeLancet2015386995100726049252 7JinXLianJSHuJHGaoJZhengLZhangYMet al.Epidemiological, clinical and virological characteristics of 74"/>
  <result pre="al.Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected" exact="disease" post="2019 (COVID-19) with gastrointestinal symptomsGut2020691002932213556 8EliezerMHautefortCHamelALVerillaudBHermanPHoudartEet al.Sudden and Complete"/>
  <result pre="coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptomsGut2020691002932213556 8EliezerMHautefortCHamelALVerillaudBHermanPHoudartEet al.Sudden and" exact="Complete" post="Olfactory Loss Function as a Possible Symptom of COVID-19JAMA"/>
  <result pre="Apr 8 [Epub ahead of print]doi:10.1001/jamaoto.2020.0832 9collab: The Novel Coronavirus" exact="Pneumonia" post="Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak"/>
  <result pre="Weekly2020211322 10NishiuraHKobayashiTMiyamaTSuzukiAJungSMHayashiKet al.Estimation of the asymptomatic ratio of novel coronavirus" exact="infections" post="(COVID-19)Int J Infect Dis202094154532179137 11MizumotoKKagayaKZarebskiAChowellGEstimating the asymptomatic proportion of"/>
  <result pre="(COVID-19)Int J Infect Dis202094154532179137 11MizumotoKKagayaKZarebskiAChowellGEstimating the asymptomatic proportion of coronavirus" exact="disease" post="2019 (COVID-19) cases on board the Diamond Princess cruise"/>
  <result pre="al.Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus" exact="Disease" post="2019 - COVID-NET, 14 States, March 1-30, 2020MMWR Morb"/>
  <result pre="Rep2020694586432298251 13ZhouFYuTDuRFanGLiuYLiuZet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China:a retrospective cohort studyLancet202039510546232171076"/>
 </snippets>
</snippetsTree>
